Outcomes of Medication Misadventure Among People With Cognitive Impairment or Dementia: A Systematic Review and Meta-analysis

Ann Pharmacother. 2021 Apr;55(4):530-542. doi: 10.1177/1060028020949125. Epub 2020 Aug 10.

Abstract

Objective: To investigate mortality and hospitalization outcomes associated with medication misadventure (including medication errors [MEs], such as the use of potentially inappropriate medications [PIMs], and adverse drug events [ADEs]) among people with cognitive impairment or dementia.

Data sources: Ovid MEDLINE, Ovid EMBASE, Ovid International Pharmaceutical Abstracts, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Central Register of Controlled Trials were searched from inception to December 2019.

Study selection and data extraction: Relevant studies using any study design were included. Reviewers independently performed critical appraisal and extracted relevant data.

Data synthesis: The systematic review included 10 studies that reported the outcomes of mortality or hospitalization associated with medication misadventure, including PIMs (n=5), ADEs (n=2), a combination of MEs and ADEs (n=2), and drug interactions (n=1). Five studies examining the association between PIMs and mortality/hospitalization were included in the meta-analyses. Exposure to PIMs was not associated with either mortality (odds ratio [OR]=1.36; 95%CI=0.79-2.35) or hospitalization (OR=1.02; 95%CI=0.83-1.26). In contrast, single studies indicated that ADEs with cholinesterase inhibitors were associated with mortality and hospitalization.

Relevance to patient care and clinical practice: Individuals with cognitive impairment or dementia are at increased risk of medication misadventure; based on relatively limited published data, this does not necessarily translate to increased mortality and hospitalization.

Conclusions: Overall, medication misadventure was not associated with mortality or hospitalization in people with cognitive impairment or dementia, noting the limited number of studies, difficulty in controlling potential confounding variables, and that most studies focus on PIMs.

Keywords: adverse drug events; cognitive impairment; dementia; hospitalization; medication errors; medication misadventure; meta-analysis; mortality.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / adverse effects
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / epidemiology*
  • Cognitive Dysfunction / psychology
  • Dementia / drug therapy*
  • Dementia / epidemiology*
  • Dementia / psychology
  • Drug-Related Side Effects and Adverse Reactions / epidemiology*
  • Drug-Related Side Effects and Adverse Reactions / psychology
  • Hospitalization / trends
  • Humans
  • Medication Errors / psychology
  • Medication Errors / trends
  • Potentially Inappropriate Medication List / trends*

Substances

  • Cholinesterase Inhibitors